comparsion of efficacy of niosomal propranolol oint 0.1% versus atenolol oint 0.1% in the treatment of infantile hemangioma
Phase 1
Recruiting
- Conditions
- Hemangioma.Haemangioma, any site
- Registration Number
- IRCT2017100935611N1
- Lead Sponsor
- vice chancellor for research of kerman university of medical scieces
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
inclusion criteria : age less than 12 month,definite diagnose of superficial hemangioma
exclusion criteria : sinus bradycardia, atrioventricular block, asthma, bronchitis, pneumonitis, maternal cardiac disease or other systemic disorder, allergy to beta blockers, history of tretmnent with beta blockers ,systemic corticosteroids, interferon, cyclophosphamide and vincristine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of lesion. Timepoint: monthly. Method of measurement: ruler.
- Secondary Outcome Measures
Name Time Method Age. Timepoint: before starting study. Method of measurement: birth certification.;Gender. Timepoint: before starting study. Method of measurement: asking.;Place of lesion. Timepoint: before starting study. Method of measurement: looking.;Time of beginning. Timepoint: before starting study. Method of measurement: asking.;Vital signe. Timepoint: monthly. Method of measurement: examing.;Lab test. Timepoint: first-second and third month. Method of measurement: laboratory.